Clarivate price target lowered to $5 from $6 at Barclays

Barclays lowered the firm’s price target on Clarivate to $5 from $6 and keeps an Underweight rating on the shares. The company’s Q2 results and lowered fiscal year organic guide once again disappointed investors, the analyst tells investors in a research note. The firm says the results and CEO change are a negative read near-term for the shares.